About AN2 Therapeutics

AN2 Therapeutics, Inc. is a biopharmaceutical company dedicated to developing therapies to treat rare, chronic, and serious infectious diseases in areas of high unmet needs. Founded by a team of experienced industry leaders in infectious disease drug research and development and boron chemistry, we have a passion for addressing the challenges of infectious disease and improving global human health. For more information, please visit www.an2therapeutics.com.

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology
location icon
Location
1800 El Camino Real, Suite D, Menlo Park, California 94027, US
description icon
Founded
2019
description icon
Keywords
Infectious Disease, Infectious Disease

AN2 Therapeutics Alternatives

Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology

Frequently Asked Questions about AN2 Therapeutics

Who is the CEO of AN2 Therapeutics?

Eric Easom is the CEO of AN2 Therapeutics. To contact Eric Easom email at [email protected] or [email protected]. Or you may call +1.6508049077

Who are the decision makers in AN2 Therapeutics?

The decision makers in AN2 Therapeutics are Alex Smith, Alexander Tung, Sundaravel Ananthavel, etc. Click to Find AN2 Therapeutics decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more